Skip to main content
. 2020 Jun 6;33(5):485–494. doi: 10.20524/aog.2020.0507

Figure 2.

Figure 2

Relative risks (RR) and 95% confidence intervals for each primary study by region and subtype (CD = Crohn’s disease; UC = ulcerative colitis. The pooled summary effects are shown at the base of the plot aligned with ‘All’. Vertical dashed lines are shown at RR=1 to indicate the null effect (confidence intervals that do not include 1 are statistically significant at P<0.05)